Endocrinology (including Diabetes Mellitus and Metabolic Disease)

Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients

1. Leonidas Palaiodimos
2. Natalia Chamorro-Pareja
3. Dimitrios Karamanis
4. Weijia Li
5. Phaedon D. Zavras
6. Kai Ming Chang
7. Priyanka Mathias
8. Damianos G. Kokkinidis

Reviewed by ScreenIT

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19

1. Sang Youl Rhee
2. Jeongwoo Lee
3. Hyewon Nam
4. Dae-Sung Kyoung
5. Dong Wook Shin
6. Dae Jung Kim

Reviewed by ScreenIT

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

1. Leonidas Palaiodimos
2. Damianos G. Kokkinidis
3. Weijia Li
4. Dimitrios Karamanis
5. Jennifer Ognibene
6. Shitij Arora
7. William N. Southern
8. Christos S. Mantzoros

Reviewed by ScreenIT

Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico

1. Omar Yaxmehen Bello-Chavolla
2. Jessica Paola Bahena-López
3. Neftali Eduardo Antonio-Villa
4. Arsenio Vargas-Vázquez
5. Armando González-Díaz
6. Alejandro Márquez-Salinas
7. Carlos A Fermín-Martínez
8. J Jesús Naveja
9. Carlos A Aguilar-Salinas

Reviewed by ScreenIT

Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center

1. Ting Xue
2. Qianwen Li
3. Qiongyao Zhang
4. Wei Lin
5. Junping Wen
6. Li Li
7. Gang Chen

Reviewed by ScreenIT

Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis

1. Yingyu Chen
2. Xiao Gong
3. Lexun Wang
4. Jiao Guo

Reviewed by ScreenIT

Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)

1. Mengyao Wu
2. Tak-Ho Lo
3. Liping Li
4. Jia Sun
5. Chujun Deng
6. Ka-Ying Chan
7. Xiang Li
8. Steve Ting-Yuan Yeh
9. Jimmy Tsz Hang Lee
10. Pauline Po Yee Lui
11. Aimin Xu
12. Chi-Ming Wong

• Curated by eLife

  eLife assessment

  These valuable findings presented by Wu et al. advance our understanding in novel cell signaling regulators of hepatic metabolism. The evidence supporting these conclusions are solid, utilizing in vivo and in vitro gain and loss of function studies. These work will be of interest to biologists working in the field of hepatic steatosis.

Reviewed by eLife

Insulin sensitivity in mesolimbic pathways predicts and improves with weight loss in older dieters

1. Lena J Tiedemann
2. Sebastian M Meyhöfer
3. Paul Francke
4. Judith Beck
5. Christian Büchel
6. Stefanie Brassen

• Curated by eLife

  Evaluation Summary:

  This is a paper that will be of particular interest to neuroscientists with a focus on food intake and neural responses to food ingestion. This paper provides new insights into how the body responds to weight loss and helps identify those that may not be successful.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

Reviewed by eLife

Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

1. Schafer Boeder
2. Emily Kobayashi
3. Gautam Ramesh
4. Brittany Serences
5. Kristen Kulasa
6. Amit R. Majithia

Reviewed by ScreenIT

Does Metformin Decrease Mortality in Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19? A Multivariable and Propensity Score-adjusted Meta-analysis

1. Zhiyuan Ma
2. Mahesh Krishnamurthy

Reviewed by ScreenIT